Start-Up Spotlight: Apama Medical, Targeting AFib With An RF-Balloon Combo
Executive Summary
Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.
You may also be interested in...
Boston Scientific Adds Single-Shot AF-Ablation Balloon With Apama Acquisition
Boston Scientific will pay about $300m for the Campbell, California-based maker of the Apama radiofrequency balloon catheter system for the treatment of atrial fibrillation. Boston Scientific plans to integrate Apama's technology with its Rhythmia HDx mapping system.
MNA Analysis: Abbott And Stryker Make Big Deals In Slow Month
February 2016 was a slow month for medtech mergers and acquisitions punctuated by three billion-dollar-plus deals.
Boston follows Medtronic's footsteps and buys into TAVI space
Boston Scientific is to buy outright a company in its investment portfolio, Sadra Medical. The firm specialises in percutaneous transcatheter aortic valve implantation (TAVI) technology and the acquisition follows in the footsteps of heart rival Medtronic, which last year bought two venture-backed TAVI companies – CoreValve and Ventor Technologies – for just under $1bn (www.clinica.co.uk, 2 March 2009).